ISIN | CH0226274212 |
---|---|
Valor Number | 22627421 |
Bloomberg Global ID | UBANF US |
Fund Name | UBS ETF (CH) - UBS MSCI Switzerland hUSD ETF USD dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The UBS ETF (CH) – MSCI Switzerland 100% hedged to USD is an exchange traded fund incorporated in Switzerland. The objective of the Fund is to deliver the net total return performance of the MSCI Switzerland 100% hedged to USD and allow intraday trading. |
Peculiarities |
Current Price * | 28.43 USD | 18.07.2025 |
---|---|---|
Previous Price * | 28.35 USD | 17.07.2025 |
52 Week High * | 29.54 USD | 20.03.2025 |
52 Week Low * | 24.66 USD | 09.04.2025 |
NAV * | 28.43 USD | 18.07.2025 |
Issue Price * | 28.43 USD | 18.07.2025 |
Redemption Price * | 28.43 USD | 18.07.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 783,740,612 | |
Unit/Share Assets *** | 783,740,612 | |
Trading Information SIX |
YTD Performance | +9.26% |
31.12.2024 - 18.07.2025
31.12.2024 18.07.2025 |
---|---|---|
YTD Performance (in CHF) | -3.41% |
31.12.2024 - 18.07.2025
31.12.2024 18.07.2025 |
1 month | +0.96% |
18.06.2025 - 18.07.2025
18.06.2025 18.07.2025 |
3 months | +6.16% |
22.04.2025 - 18.07.2025
22.04.2025 18.07.2025 |
6 months | +5.10% |
20.01.2025 - 18.07.2025
20.01.2025 18.07.2025 |
1 year | +6.34% |
18.07.2024 - 18.07.2025
18.07.2024 18.07.2025 |
2 years | +23.85% |
18.07.2023 - 18.07.2025
18.07.2023 18.07.2025 |
3 years | +32.41% |
18.07.2022 - 18.07.2025
18.07.2022 18.07.2025 |
5 years | +48.47% |
20.07.2020 - 18.07.2025
20.07.2020 18.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 18.07.2025 |
Nestle SA | 14.44% | |
---|---|---|
Novartis AG Registered Shares | 12.78% | |
Roche Holding AG | 12.69% | |
UBS Group AG Registered Shares | 6.17% | |
Zurich Insurance Group AG | 5.67% | |
Compagnie Financiere Richemont SA Class A | 5.62% | |
ABB Ltd | 5.23% | |
Swiss Re AG | 2.89% | |
Lonza Group Ltd | 2.85% | |
Givaudan SA | 2.48% | |
Last data update | 30.06.2025 |
TER | 0.25% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.23% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |